Results Healthcare   |   Results International

CROs and CMOs

We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

CROs and CMOs

Clinical/contract research organisations (CROs) in particular are among the strongest growth sectors of the pharmaceutical industry, with many firms across the sector experiencing double- digit annual growth. This growth is driven by the trend for increased outsourcing by pharmaceutical and biotechnology companies looking to shift fixed to variable costs and access specialist capabilities not found in-house, and an overall increase in biopharmaceutical R&D spending. CROs have also become one of the most active sectors for M&A, with larger players consolidating to achieve critical mass, as well as completing bolt-on acquisitions to offer a more comprehensive service offering.

Our team has a strong track-record in successful CRO transactions.

17 May 2018

Breaking Down The Trump Administrations’ Proposed Initiatives to Address High Pharma Prices

Last Friday in the White House Rose Garden, President Trump delivered remarks outlining his administration’s plans to lower drug prices…

26 Jan 2017

Pharma & Biotech 2017 – Review of Outsourced Manufacturing

This report provides an in-depth review of the pharmaceutical outsourced manufacturing sector, including latest data on the pharmaceutical and CMO…


Weekly Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office